References
- Bunn P Jr. The expanding role of cisplatin in the treat-ment of non-small cell lung cancer. Semin Oncol 1989; 16 (suppl. 6), 10-21.
- Lin RJ. Chemotherapy outcomes in advanced non-small cell lung cancer. Semin Oncol 1993; 20: 296–301.
- Folman RS, Rosman M. The role of chemotherapy in non-small cell lung cancer. The community perspective. Semin Oncol 1988; 15 (Suppl. 4): 16-21.
- Mabel JA, Little AD. Therapeutic synergism in murine tumors for combination of cis-diamine-dichloroplatinum with VP-16-213 of BCNU. Proc Am Assoc Cancer Research 1979; 20: 230.
- Klastersky J. Therapy with cisplatin and etoposide for non-small cell lung cancer. Semin Oncol 1986; 13 (Suppl 3): 104–114.
- Dhingra HM, Valdivieso M, Carr DT, et al. Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small cell lung cancer. J Chin Oncol 1985; 3: 176–183.
- Splinter T, Kok T, Kho S, et al. A multi-center phase II trial of cisplatin and oral etoposide (VP-16) in inoperable non-small cell lung cancer. Semin Oncol 1986; 13 (suppl. 3): 97-103.
- World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. Geneva WHO Offset publication 1979, No 48.
- Woolson RF. Comparison of two groups. T-test and rank-tests. In: Statistical methods for the analysis of biomed-ical data. New York, Wiley, 1987.
- Ganz PA, Figlin RA, Haskell CM, La-soto N, Sian J. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer 1989; 63: 1271–1278.
- Kaasa S, Lund E, Thorud E, Hatlevoll R, Host H. Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer 1991; 67: 2443–2447.
- Gralla RJ, Kris MG. Chemotherapy in non-small cell lung cancer. Results of recent trials. Semin Oncol 1988; (Suppl.) 15: 2-5.
- Kris MG, Gralla RJ, Wertheim MS, Kelsen DP, 0' Connell JP, Burke MT. Trial of the combination of mito-mycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer. Cancer Treat Rep 1986; 70: 1091–1096.
- Ruckdeschel JC, Finkelstein DM, Mason BA, Creech RH. Chemotherapy for metastatic non-small cell bron-chogenic carcinoma: EST 2575, generation V. A randomized comparison of four cisplatin-containing regimens. J Chin Oncol 1985; 3: 72–79.
- Longeval E, Klastersky J. Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party. Cancer 1982; 50: 2751–2756.
- Ruckdeschel JC, Finkelstein DM, Ettinger DS, et al. A randomized trial of the most active regimens for metastatic non-small cell lung cancer. J Clin Oncol 1986; 4: 14–22.
- Paccaguella A, Favaretto A, Brandes A, et al. Cisplatin, etoposide and ifosfamide in non-small-cell lung carcinoma. Cancer 1990; 65: 2631–2634.